TCRR - Tcr2 Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

Tcr2 Therapeutics's activity chart (see below) currently has 52 price targets and 46 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 21.71% of the time, taking 88.59 days on average.

Most recent stock forecast was given by MARA GOLDSTEIN from MIZUHO on 12-May-2023. First documented stock forecast 11-Mar-2019.

Best performing analysts who are covering TCRR - Tcr2 Therapeutics:

David Nierengarten Raghuram Selvaraju Mara Goldstein Jonathan Chang Tony Butler

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 12-May-2023

$2.11

$1.72

3 years 6 months 9 days ago
(12-May-2023)

2/7 (28.57%)

$0.15 (7.65%)

86

Hold Since 31-May-2019

$2

$2

3 years 7 months 29 days ago
(23-Mar-2023)

1/3 (33.33%)

$0.58 (40.85%)

4

Buy Since 21-Sep-2021

$3

3 years 8 months 13 days ago
(08-Mar-2023)

0/2 (0%)

$1.4 (87.50%)

Buy Since 14-Dec-2020

3 years 8 months 14 days ago
(07-Mar-2023)

0/3 (0%)

$15.09 (385.93%)

Buy Since 11-Mar-2019

$26

3 years 10 months 15 days ago
(06-Jan-2023)

0/5 (0%)

$19.92 (327.63%)

Show more analysts

Please expand the browser size to see the chart

What is TCRR (Tcr2 Therapeutics) average time for price targets to be met?

On average it took 89 days for the stock forecasts to be reached, with an average price target met ratio of 21.71%.

Which analyst most recently updated their price target on TCRR (Tcr2 Therapeutics)?

Mara Goldstein

Which analyst has the most public recommendations on TCRR (Tcr2 Therapeutics)?

Mara Goldstein works at MIZUHO and has 11 price targets and 10 ratings on TCRR

Which analyst is the currently most bullish on TCRR (Tcr2 Therapeutics)?

Matthew Luchini with the highest potential upside of $36.52

Which analyst is the currently most reserved on TCRR (Tcr2 Therapeutics)?

Do Kim with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?